NSAIDs mechanism of action (WP5513)
Homo sapiens
"Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit the cyclooxygenase isoenzymes COX1 and COX2 with varying degrees of specificity for the COX2 isoform. As a result, the conversion of arachidonic acid to prostaglandins (PGs) is inhibited. The main effects of PGs throughout the body are listed." Inspired by Figure 1 in PMID:32322101.
Authors
Eric WeitzActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
Annotations
Pathway Ontology
drug pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
Diclofenac | Metabolite | drugbank:DB00586 | |
PGD2 | Metabolite | chebi:15555 | |
PGE2 | Metabolite | chebi:15551 | |
PGF2a | Metabolite | chebi:15553 | |
PGI2 | Metabolite | chebi:15552 | |
PGG2 | Metabolite | chebi:27647 | |
PGH2 | Metabolite | chebi:15554 | |
PGA1 | Metabolite | chebi:15545 | |
PGE1 | Metabolite | chebi:15544 | |
Ibuprofen | Metabolite | drugbank:DB01050 | |
Naproxen | Metabolite | drugbank:DB00788 | |
Celecoxib | Metabolite | drugbank:DB00482 | |
Rofecoxib | Metabolite | drugbank:DB00533 |
References
- Cardiovascular effects and safety of (non-aspirin) NSAIDs. Schjerning AM, McGettigan P, Gislason G. Nat Rev Cardiol. 2020 Sep;17(9):574–84. PubMed Europe PMC Scholia